Procept BioRobotics CorpPRCT
Price$17.02Intrinsic value$94.92458% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $337.3M+50.3% YoYTTM through 30 Jun 2026
Net Income -$109.8MTTM through 30 Jun 2026
Free Cash Flow -$84.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin64.9%
EBITDA Margin-31.8%
Operating Margin-39.3%
Net Margin-32.5%

Returns

-29.5%ROE
-21.0%ROA

Balance Sheet Health

Debt / Equity0.15x
Current Ratio6.73x
Net Debt-$193.9Mnet cash position
Cash & Equivalents$227.9M

Quality Metrics

Altman Z-Score3.28
Piotroski F-Score3 / 9
FCF Margin-25.2%
Rule of 40-8.0
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $308.1M
Diluted EPS-$1.95TTM
'20'21'22'23'24'25
FY2025: $-1.72

Dividend

No dividend

Capital Allocation

R&D Spend$78.8M
Capex Intensity3.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.